The most commonly accepted prostate cancer treatments in the United States are surgery to remove the prostate and radiation therapy. There have been technological advances in both surgery and radiation over the past 10 years such as Robotic Assisted Surgery, Intensity Modulated Radiation Therapy, Cyberknife Radiosurgery (hypo-fractionated radiation) and Proton Beam Radiation. These advancements have helped to reduce common side effects such as erectile dysfunction and urinary leakage or incontinence. However, even in expert hands erectile dysfunction may occur in over 50% of patients and urinary leakage requiring pad protection may occur in over 20% of men.
It is being increasingly recognized that prostate cancer is being OVER treated in many men and this has led the U.S. Preventive Services Task Force to give PSA screening a "C" rating, meaning that the overall benefit may be small and that the harms of PSA screening outweigh the survival benefits. PSA screening can lead to a reflex prostate biopsy, and even men with minimal disease were treated traditionally with surgery or radiation—resulting in significant quality of life related side effects.
Today, many men are not offered any alternatives to traditional treatment by their urologists. At the Scionti Prostate Center, we discuss all treatments options and recommend LESS invasive treatment options whenever possible.
Minimally invasive prostate cancer treatment means delivering cancer treatment to the prostate without having to do surgery, without making major incisions. This is called ablation (destruction) which is accomplished by precisely targeting lethal energy to diseased prostate tissue, based on tumor locations revealed by Advanced Diagnostics. The advantages are:
a) quick recovery,
b) no incisions,
c) less collateral damage to neighboring structures
d) better preservation of sexual and urinary function
e) precision individualized treatment
f) leaves all treatment options available if more treatment is needed in the future.
The whole concept of minimally invasive ablative therapy is an exciting frontier in which the Scionti Prostate Center has taken the lead. We have the ability to use advanced MRI fusion to target specific tumor regions in the prostate or to treat the entire gland if that is necessary. Our most effective and precise treatment is MRI Fusion Guided HIFU. Dr. Scionti has pioneered the MRI Mapped Energy Modulated HIFU Technique ( MMM Triple M HIFU)
Dr. Scionti was formerly the Director of Prostate Cancer Ablative Surgery at the Joel E. Smilow Comprehensive Prostate Cancer Center at NYU Langone Medical Center in New York City.
Dr. Scionti has the largest cumulative prostate ablative treatment experience in North America with over 2500 patients treated over the past 15 years.